- Alternative title
-
Molekulare Mechanismen der RIG-I vermittelten Antitumorantwort
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
München, Technische Universität München, Dissertation, 2022
- Keyword
-
Tiermodell
- Event
-
Veröffentlichung
- (where)
-
München
- (who)
-
Universitätsbibliothek der TU München
- (when)
-
2022
- Creator
-
Kreppel, Diana Alexandra
- Contributor
- URN
-
urn:nbn:de:bvb:91-diss-20220722-1611325-1-2
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:50 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kreppel, Diana Alexandra
- Poeck, Hendrik
- Jellusova, Julia
- Busch, Dirk H.
- Universitätsbibliothek der TU München
Time of origin
- 2022
Other Objects (12)
RNA binding regulates TRIM25-mediated RIG-I ubiquitination
Tumor cell-intrinsic RIG-I signaling regulates anti-tumor T-cell immunity through programmed cell death and extracellular vesicle biogenesis
Regulation og RIG-I-mediated anti viral innate immunity
RIG-I-induced antitumor immunity is driven by immunogenic tumor cell-derived extracellular vesicles
Ionizing radiation improves RIG-I mediated immunotherapy through enhanced p53 activation in malignant melanoma
RIG-I Ligand in der Therapie der Influenza-Infektion
Der RIG-I Ligand 3pRNA aktiviert humane Natürliche Killerzellen zur Tumorlyse und induziert RIG-I/3pRNA tragende anti-tumorale Tumorexosomen
Modulation of antitumor immunity by isocitrate dehydrogenase-mutated tumors
Role of RIG-I like receptors in hematopoietic stem cells
12/15-lipoxygenase and its role in anti-tumor immunity
Transcutaneous immunization with CD40 ligation boosts cytotoxic T lymphocyte mediated antitumor immunity independent of CD4 helper cells in mice
Novel therapeutic strategies and modulators of anti-tumor immunity in melanoma
RNA binding regulates TRIM25-mediated RIG-I ubiquitination
Tumor cell-intrinsic RIG-I signaling regulates anti-tumor T-cell immunity through programmed cell death and extracellular vesicle biogenesis
Regulation og RIG-I-mediated anti viral innate immunity
RIG-I-induced antitumor immunity is driven by immunogenic tumor cell-derived extracellular vesicles
Ionizing radiation improves RIG-I mediated immunotherapy through enhanced p53 activation in malignant melanoma
RIG-I Ligand in der Therapie der Influenza-Infektion
Der RIG-I Ligand 3pRNA aktiviert humane Natürliche Killerzellen zur Tumorlyse und induziert RIG-I/3pRNA tragende anti-tumorale Tumorexosomen
Modulation of antitumor immunity by isocitrate dehydrogenase-mutated tumors
Role of RIG-I like receptors in hematopoietic stem cells
12/15-lipoxygenase and its role in anti-tumor immunity
Transcutaneous immunization with CD40 ligation boosts cytotoxic T lymphocyte mediated antitumor immunity independent of CD4 helper cells in mice
Novel therapeutic strategies and modulators of anti-tumor immunity in melanoma
RNA binding regulates TRIM25-mediated RIG-I ubiquitination
Tumor cell-intrinsic RIG-I signaling regulates anti-tumor T-cell immunity through programmed cell death and extracellular vesicle biogenesis
Regulation og RIG-I-mediated anti viral innate immunity
RIG-I-induced antitumor immunity is driven by immunogenic tumor cell-derived extracellular vesicles
Ionizing radiation improves RIG-I mediated immunotherapy through enhanced p53 activation in malignant melanoma
RIG-I Ligand in der Therapie der Influenza-Infektion
Der RIG-I Ligand 3pRNA aktiviert humane Natürliche Killerzellen zur Tumorlyse und induziert RIG-I/3pRNA tragende anti-tumorale Tumorexosomen
Modulation of antitumor immunity by isocitrate dehydrogenase-mutated tumors
Role of RIG-I like receptors in hematopoietic stem cells
12/15-lipoxygenase and its role in anti-tumor immunity
Transcutaneous immunization with CD40 ligation boosts cytotoxic T lymphocyte mediated antitumor immunity independent of CD4 helper cells in mice